Advertisement

Contrast Echocardiography

  • Farimah Aminian
  • Harald Becher
Chapter

Abstract

Contrast echocardiography is an enhanced ultrasound imaging technique utilizing a contrast agent to increase blood echogenicity in cardiac chambers or myocardial microvessels. This technique can improve image quality and provide interpretable recordings in cases with suboptimal acoustic window like ventilated or obese patients. Contrast enhancement can be used during transthoracic, transesophageal and stress echocardiography.

Clinical applications for contrast echocardiography are classified into four main categories: Left ventricular opacification, Detection of intracardiac shunt, Doppler signal enhancement and assessment of myocardial perfusion.

Keywords

Echocardiography Contrast imaging 

Abbreviations

CAD

Coronary artery disease

EBD

Endocardial border delineation

EF

Ejection fraction

IV

Intravenous

LV

Left ventricle

LVO

Left ventricular opacification

MBF

Myocardial blood flow

MCE

Myocardial contrast echocardiography

PFO

Patent foramen ovale

TEE

Transesophageal echocardiography

UCA

Ultrasound contrast agent

References

  1. 1.
    Porter TR, Abdelmoneim S, Belcik JT, McCulloch ML, Mulvagh SL, Olson JJ, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American society of echocardiography. J Am Soc Echocardiogr. 2014;:797–810.CrossRefGoogle Scholar
  2. 2.
    Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig M, et al. ASE consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr. 2008;21:1179–201.CrossRefGoogle Scholar
  3. 3.
    Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr. 2009;10:194–212.CrossRefGoogle Scholar
  4. 4.
    Olszewski R, Timperley J, Szmigielski C, Monaghan M, Nihoyannopoulos P, Senior R, et al. The clinical applications of contrast echocardiography. Eur J Echocardiogr. 2007;8:S13–23.CrossRefGoogle Scholar
  5. 5.
    Thanigaraj S, Schechtman KB, Perez JE. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement. J Am Soc Echocardiogr. 1999;12(12):1022–6.CrossRefGoogle Scholar
  6. 6.
    Soman P, Swinburn J, Callister M, Stephens NG, Senior R. Apical hypertrophic cardiomyopathy: bedside diagnosis by intravenous contrast echocardiography. J Am Soc Echocardiogr. 2001;14(4):311–3.CrossRefGoogle Scholar
  7. 7.
    Koo BK, Choi D, Ha JW, Kang SM, Chung N, Cho SY. Isolated noncompaction of the ventricular myocardium: contrast echocardiographic findings and review of the literature. Echocardiography. 2002;19(2):153–6.CrossRefGoogle Scholar
  8. 8.
    Moreno R, Zamorano JL, Almeria C, Rodrigo JL, Villate A, Serra V, et al. Usefulness of contrast agents in the diagnosis of left ventricular pseudoaneurysm after acute myocardial infarction. Eur J Echocardiogr. 2002;3(2):111–6.CrossRefGoogle Scholar
  9. 9.
    Soliman OII, Geleijnse ML, Meijboom FJ, Nemes A, Kamp O, Nihoyannopoulos P, et al. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr. 2007;8:S2–12.CrossRefGoogle Scholar
  10. 10.
    Kaul S. Myocardial contrast echocardiography: a 25-year retrospective. Circulation. 2008;118(3):291–308.CrossRefGoogle Scholar
  11. 11.
    McCulloch M, Gresser C, Moos S, Odabashian J, Jasper S, Bednarz J, et al. Ultrasound contrast physics: a series on contrast echocardiography. J Am Soc Echocardiogr. 2000;13:959–67.CrossRefGoogle Scholar
  12. 12.
    Stewart MJ. Contrast echocardiography. Heart. 2003;89(3):342–8.CrossRefGoogle Scholar
  13. 13.
    GE Healthcare. OPTISON prescribing information. 2012.Google Scholar
  14. 14.
    Luminity Summary of Product Characteristics. 2011.Google Scholar
  15. 15.
    EMEA. Scientific discussion. SonoVue: European Public Assessment Report; 2016.Google Scholar
  16. 16.
    Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. Am J Cardiol. 2008;102(12):1742–6.CrossRefGoogle Scholar
  17. 17.
    Shaikh K, Chang SM, Peterson L, Rosendahl-Garcia K, Quinones MA, Nagueh SF, et al. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol. 2008;102:1444–50.CrossRefGoogle Scholar
  18. 18.
    Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, et al. The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21(11):1202–6.CrossRefGoogle Scholar
  19. 19.
    Parker JM, Weller MW, Feinstein LM, Adams RJ, Main ML, et al. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol. 2013;112:1039–45.CrossRefGoogle Scholar
  20. 20.
    Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SAC, Hagen ME, et al. Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study. Circ Cardiovasc Imaging. 2010;3(3):240–8.CrossRefGoogle Scholar
  21. 21.
    Wever-Pinzon O, Suma V, Ahuja A, Romero J, Sareen N, Henry SA, et al. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. Eur Heart J Cardiovasc Imag. 2012;13:857–62.CrossRefGoogle Scholar
  22. 22.
    Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol. 2009;53(1):32–8.CrossRefGoogle Scholar
  23. 23.
    Becher H, Burns PN. Assessment of left ventricular function by contrast echo. Handbook of contrast echocardiography. Berlin: Springer; 2000. p. 47–79.Google Scholar
  24. 24.
    Nakatani S, Imanishi T, Terasawa A, Beppu S, Nagata S, Miyatake K. Clinical application of transpulmonary contrast-enhanced Doppler technique in the assessment of severity of aortic stenosis. J Am Coll Cardiol. 1992;20(4):973–8.CrossRefGoogle Scholar
  25. 25.
    Nakatani S, Satoshi T. Contrast-enhanced Doppler in the assessment of aortic stenosis. In: Nanda NC, Schleif R, Goldberg BB, editors. Advances in echo imaging using contrast enhancement. Dordrecht: Springer; 1997. p. 253–61.CrossRefGoogle Scholar
  26. 26.
    Dubourg O, Delorme G, Jondeau G, Chikli F, Clavier H, Valtier B, et al. Simultaneous measurement of systolic pulmonary artery pressure by catheterization and contrast enhancement doppler echocardiography. Arch Mal Coeur Vaiss. 1993 Dec;86(12):1721–7.PubMedGoogle Scholar
  27. 27.
    Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802–10.CrossRefGoogle Scholar
  28. 28.
    Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:77–84.CrossRefGoogle Scholar
  29. 29.
    Jung PH, Mueller M, Schuhmann C, Eickhoff M, Schneider P, Seemueller G, et al. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events. Cardiovasc Ultrasound. 2013;11:1–5.CrossRefGoogle Scholar
  30. 30.
    Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R, et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial. JACC Cardiovasc Imaging. 2008;1(2):145–52.CrossRefGoogle Scholar
  31. 31.
    Gaibazzi N, Reverberi C, Lorenzoni V, Molinaro S, Porter TR. Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography. Circulation. 2012;126(10):1217–24.CrossRefGoogle Scholar
  32. 32.
    Lepper W, Shivalkar B, Rinkevich D, Belcik T, Wei K. Assessment of the vascularity of a left ventricular mass using myocardial contrast echocardiography. J Am Soc Echocardiogr. 2002;15(11):1419–22.CrossRefGoogle Scholar
  33. 33.
    Janardhanan R, Senior R. Accuracy of dipyridamole myocardial contrast echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease early after acute myocardial infarction. J Am Coll Cardiol. 2004;43(12):2247–52.CrossRefGoogle Scholar
  34. 34.
    Arnold JR, Karamitsos TD, Pegg TJ, Francis JM, Olszewski R, Searle N, et al. Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance. JACC Cardiovasc Imaging. 2010;3(9):934–43.CrossRefGoogle Scholar
  35. 35.
    Zamorano JL, García-Fernández MA. Contrast echocardiography in clinical practice, vol 1. Mailand: Springer; 2004. p. 241.CrossRefGoogle Scholar
  36. 36.
    Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Quinones MA, Espada R, et al. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation. 2002;106(8):950–6.CrossRefGoogle Scholar
  37. 37.
    Janardhanan R, Moon JC, Pennell DJ, Senior R. Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction. Am Heart J. 2005;149:355–62.CrossRefGoogle Scholar
  38. 38.
    Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Verani MS, Quinones MA, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003;107:538–44.CrossRefGoogle Scholar
  39. 39.
    Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473–83.CrossRefGoogle Scholar
  40. 40.
    Abdelmoneim SS, Basu A, Bernier M, Dhoble A, Abdel-Kader SS, Pellikka PA, et al. Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Diab Vasc Dis Res. 2011;8(4):254–61.CrossRefGoogle Scholar
  41. 41.
    Madua EC, Potua C, Baugh D, Tulloch-Reid E. Myocardial contrast echocardiography in the evaluation of hypertensive heart disease. Cardiol Res. 2011;2(6):259–68.Google Scholar
  42. 42.
    Main ML, Goldman JH, Grayburn PA. Thinking outside the “Box”—the ultrasound contrast controversy. J Am Coll Cardiol. 2007;50(25):2434–7.CrossRefGoogle Scholar
  43. 43.
    Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 2004;3(6):5–32.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Farimah Aminian
    • 1
  • Harald Becher
    • 1
  1. 1.Echocardiography DepartmentRazavi HospitalMashhadIran

Personalised recommendations